Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.665 USD | +4.51% | -18.00% | -17.75% |
Mar. 21 | Earnings Flash (ARMP) ARMATA PHARMACEUTICALS Reports Q4 Revenue $1.5M | MT |
Mar. 21 | Armata Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | 4.64M | Sales 2025 * | 2.75M | Capitalization | 92.18M |
---|---|---|---|---|---|
Net income 2024 * | -49M | Net income 2025 * | -63M | EV / Sales 2024 * | 19.9 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 33.5 x |
P/E ratio 2024 * |
-1.91
x | P/E ratio 2025 * |
-1.96
x | Employees | 66 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 29.65% |
1 day | +8.97% | ||
1 week | -14.50% | ||
Current month | -33.52% | ||
1 month | -26.49% | ||
3 months | -28.75% | ||
6 months | +40.34% | ||
Current year | -14.24% |
Managers | Title | Age | Since |
---|---|---|---|
Deborah Birx
CEO | Chief Executive Officer | 68 | 23-07-10 |
Mina Pastagia
CTO | Chief Tech/Sci/R&D Officer | - | 20-10-25 |
Bryan Kadotani
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 20-02-11 | |
Joseph Patti
BRD | Director/Board Member | 60 | 19-05-08 |
Jules Haimovitz
BRD | Director/Board Member | 73 | 21-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 2.665 | +4.51% | 9 191 |
24-04-18 | 2.55 | +2.00% | 31,040 |
24-04-17 | 2.5 | -21.88% | 34,486 |
24-04-16 | 3.2 | -0.93% | 1,695 |
24-04-15 | 3.23 | -0.62% | 10,265 |
Delayed Quote Nyse, April 19, 2024 at 09:40 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.24% | 92.18M | |
-1.10% | 41.35B | |
+42.66% | 40.38B | |
+3.29% | 39.05B | |
-12.11% | 26.67B | |
+3.06% | 24.07B | |
-23.51% | 18.36B | |
-3.02% | 11.68B | |
+23.03% | 11.6B | |
+7.64% | 11.15B |
- Stock Market
- Equities
- ARMP Stock